関係会社株式評価損、従業員数 - 医薬品、繰延税金資産他1件
- 【期間】
| 年度 | 関係会社株式評価損 | 従業員数 - 医薬品 | 繰延税金資産 | 非流動負債合計 |
|---|
| 2008/03 | - | | - | | 334億 | | - | |
| 2009/03 | - | | - | | 347億 | +3.8% | - | |
| 2010/03 | - | | - | | 495億 | +42.7% | - | |
| 2011/03 | - | | - | | 531億 | +7.3% | - | |
| 2012/03 | 348億 | | - | | 510億 | -3.8% | - | |
| 2013/03 | - | | - | | 460億 | -9.9% | - | |
| 2014/03 | - | | - | | 569億 | +23.8% | - | |
| 2015/03 | - | | - | | 605億 | +6.4% | - | |
| 2016/03 | - | | - | | 864億 | +42.7% | - | |
| 2017/03 | - | | - | | 855億 | -1% | - | |
| 2018/03 | - | | - | | 140億 | -83.6% | 0.79兆 | |
| 2019/03 | - | | 6,954 | | - | | 0.81兆 | +3.4% |
| 2020/03 | - | | 7,272 | +4.57% | - | | 1.1兆 | +34.9% |
| 2021/03 | - | | 7,634 | +4.98% | - | | 1.42兆 | +29% |
| 2022/03 | - | | 7,784 | +1.96% | - | | 1.43兆 | +1.1% |
| 2023/03 | - | | 7,037 | -9.6% | - | | 1.4兆 | -2.4% |
| 2024/03 | - | | - | | - | | 1.33兆 | -5.1% |
